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Cheong-Hee Chang,* Sylvie Guerder,§ II molecules is therefore crucial to regulate immune re-
sponses. Specifically, the lack of MHC class II expres-Soon-Cheol Hong,* Willem van Ewijk,³
sion can cause immunodeficiency (reviewed by Machand Richard A. Flavell²
et al., 1994), whereas aberrant expression might result*Section of Immunobiology
in autoimmune responses.²Howard Hughes Medical Institute
The molecular mechanisms responsible for the regu-Yale School of Medicine
lation of MHC class II gene expression in B cells haveNew Haven, Connecticut 06510
been extensively studied (reviewed by Glimcher and³Erasmus University
Kara, 1992). Many cis regulatory elements have beenDepartment of Immunology
identified and DNA binding proteins have been charac-3000 DR Rotterdam
terized that could potentially be involved in the regula-The Netherlands
tion of MHC class II gene expression. The conserved
promoter elements, X, Y, and W boxes are present in
all class II genes including human and mouse. The XSummary
box, subdivided into X1 and X2 boxes, has shown to be
sufficient for B cell±specific expression (Sloan and Boss,CIITA activates the expression of multiple genes in-
1988; Tsang et al., 1988; Sloan et al., 1992) and is re-volved in antigen presentation and it is believed to
quired for interferon-g (IFNg) induction (Boss and Strom-be required for both constitutive and IFNg-inducible
inger, 1986; Basta et al., 1988; Tsang et al., 1988, 1990;expression of these genes. To understand the role of
Sloan et al., 1992). The X box is recognized by multipleCIITA in vivo, we have used gene targeting to generate
proteins, RFX (Reith et al., 1988), X2BP (Hasegawa andmice that lack CIITA. CIITA-deficient (2/2) mice do
Boss, 1991), and hXBP-1 (Liou et al., 1990; Ono et al.,not express conventional MHC class II molecules on
1991). The Y box element, an inverted CCAAT sequence,the surface of splenic B cells and dendritic cells. In
binds the factor NF-Y (Hooft van Huijsduijnen et al.,addition, macrophages resident in the peritoneal cav-
1990) and functions to augment X box±directed expres-ity do not express MHC class II molecules upon IFNg
sion (Hasegawa et al., 1993; Riley et al., 1995). W boxstimulation nor do somatic tissues of mice injected
elements and factors are the least conserved and char-with IFNg, in contrast with wild-type mice. The levels
acterized although several studies showed the signifi-of Ii and H-2M gene transcripts are substantially de-
cance of W box in both B cell±specific and IFNg-induc-creased but not absent in CIITA (2/2) mice. The tran-
ible expression (Basta et al., 1988; Tsang et al., 1988,
scription of nonconventional MHC class II genes is,
1990; Cogswell et al., 1991; Sloan et al., 1992; Hasegawa
however, not affected by CIITA deficiency. A subset of
et al., 1993).
thymic epithelial cells express MHC class II molecules.
Bare lymphocyte syndrome (BLS) is a hereditary se-
Nonetheless, very few mature CD4 T cells are present vere combined immunodeficiency disease. It is charac-
in the periphery ofCIITA (2/2) mice despite MHC class terized by the lack of HLA class II gene expression and
II expression in the thymus. Consequently, CIITA (2/2) a reduced number of mature CD4 T cells in the periphery
mice are impaired in T-dependent antigen responses of BLS patients (Mach et al., 1994). There is genetic
and MHC class II±mediated allogeneic reponses. heterogeneity among BLS patients and studies demon-
strated two distinct biochemical phenotypes that have
Introduction been subsequently groupedas A, B, and C. Cells derived
from patients in group A and the in vitro-generated mu-
Major histocompatibility complex (MHC) class II mole- tant Raji cell line RJ2.2.5 show intact MHC class II struc-
cules are heterodimeric cell surface glycoproteins tural genes and the normal profile of DNA binding pro-
whose expression is critical for the development of CD4 teins to the MHC class II promoter elements (Kara and
T cells and the ability of the vertebrate to mount an Glimcher, 1991). These results suggested that the re-
immune response. These molecules are expressed on quirement of other factor(s) necessary to activate class
antigen-presenting cells such as B cells, macrophages, II genes. Recently it has been shown that a cDNA encod-
and dendritic cells, which take up, process, and present ing a factor called CIITA can complement MHC class II
antigens to CD4 T cells. The expression of MHC class expression in these cells and that the defect in BLS-2
II on B cells is required for the collaboration between B cells and RJ2.2.5 is caused by a mutation in a splice
and T cells that is necessary for an efficient antibody junction of an exon of the CIITA gene and deletion of a
response. These molecules are also expressed on epi- part of the CIITA gene, respectively (Steimle et al., 1993).
thelial cells of the thymus, where CD4 T cells go through CIITA is required for both constitutive and IFNg-induc-
positive and negative selection to generate the mature ible expression of MHC class II genes (Steimle et al.,
T cell repertoire. The proper expression of MHC class 1993, 1994; Chang et al., 1994). In addition, introduction
of the CIITA gene driven by a constitutive promoter is
sufficient to activate MHC class II genes in plasmacy-§Present address: Centre d'Immunologie Institut National de la
toma cells or mouse T cells where MHC class II genesSanteÂ et de la Recherche MeÂ dicale, Centre National de la Recherche
are not normally expressed (Silacci et al., 1994; ChangScientifique, Parc Scientifique et Technologique, de Luminy-Case
906, 13288 Marseille, Cedex 9, France. et al., 1995). Furthermore, in cell lines CIITA regulates
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the expression of HLA-DM and invariant chain (Ii) genes
that are involved in antigen presentation (Chang and
Flavell, 1995; Chin et al., 1995; Kern et al., 1995). To
ascertain the role of CIITA in vivo, we have used gene
targeting to generate CIITA-deficient (2/2) mice. In this
study, we show that CIITA is a critical transcriptional
factor for the expression of conventional MHC class II
genes as well as Ii and H-2M genes in vivo and that
CIITA (2/2) mice can be utilized as a model system
for human BLS type II. However, nonconventional MHC
class II gene transcription does not require CIITA.
Results
Generation of CIITA (2/2) Mice
Since the structure of the mouse CIITA genomic DNA
is not yet characterized, we screened a mouse genomic
DNA l phage library derived from the 129/Sv strain. The
probe used for the screening was prepared by reverse
transcriptase-polymerase chain reaction (RT±PCR) us-
ing mouse B cells with a set of primers from 2881±2901
and 3331±3351 nt. (The numbers correspond to human
cDNA sequence published by Steimle et al., 1993). A
defect in this region in human CIITA results in MHC
class II deficiency. Preliminary studies showed that the
sequence of this region is conserved between human
and mouse (data not shown). Positive phage clones
were partially mapped and a targeting vector was con-
structed by replacing a fragment containing exons
shown to be critical for CIITA function and together with
downstream sequences with a neomycin-resistance
gene (Figure 1A). The herpes simplex virus±thymidine
kinase gene was placed 10 kb downstream of the CIITA
gene for negative selection against nonhomologous in-
tegration. The targeting vector was transfected into em-
bryonic stem cells by electroporation, and transfectants
were selected with G418 and gancyclovir. Resistant
clones were screened by PCR and homologous recom-
binants were confirmed by Southern blot analyses. Four
clones were identified and injected into C57BL/6J blas-
tocysts to generate chimeric mice. We obtained two
lines of germline-transmitted mice carrying the mutation
at the CIITA locus and homozygous mice were gener- Figure 1. Construction of Targeting Vector and Southern Blot
Analysisated by intercrosses of heterozygous mice (Figure 1B).
Homozygous mice do not express detectable levels of (A) The line represents the genomic sequences of CIITA locus.
Closed and shaded boxes represent neo and tk cassette, respec-CIITA mRNA, whereas wild-type mice do express CIITA
tively. Arrows indicate primers used for PCR to screen homologousmessage, confirming that the substitution introduced in
recombinants. The probe used for Southern blot analysis is shownthe CIITA gene results in a null mutation (Figure 1C).
at the bottom. Abbreviations for restriction sites are as follows: B,
CIITA (2/2) mice appeared healthy and exhibited no BamHI; Xb, XbaI; Xh, XhoI; RI, EcoRI.
pathologic changes by gross examination when housed (B) Analysis of offspring from CIITA heterozygote intercrosses. Tail
under specific pathogen-free conditions. DNA was digested with BamHI and EcoRI and analyzed by Southern
blotting with the probe indicated in (A). Wild-type and the recom-
bined alleles are shown.
MHC Class II Gene Expression on B Cells (C) Northern blot analysis of poly(A)1 mRNA from CIITA (1/1) and
and Dendritic Cells of CIITA (2/2) Mice CIITA (2/2) mice. The membrane was hybridized with a probe de-
rived from the human CIITA cDNA (DraIII±NotI).We first tested the constitutive expression of MHC class
II molecules on B cells by staining total splenocytes with
antibodies recognizing B cells (B220) and MHC class
II (I-Ab). As shown in Figure 2A, I-A expression is not stimulated inaddition with these same agents and prolif-
erated normally compared with wild type (data notdetectable in B cells derived from CIITA (2/2) mice.
Likewise, I-A expression is not inducible upon stimula- shown). These data suggest that the lack of MHC class
II induction by these stimuli is not due to a global defecttion of B cells with either lipopolysaccharide or interleu-
kin-4 (IL-4). In contrast, B cells from CIITA (2/2) mice in the signaling pathway of B cell activation in CIITA
(2/2) mice.up-regulated the costimulatory molecule B7-2 when
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To determine whether all MHC class II genes are af-
fected by CIITA deficiency, the expression of the non-
conventional MHC class II genes, H-2Oa and H-2Ob
was tested (Wake and Flavell, 1985; Karlsson et al., 1991;
Karlsson and Peterson, 1992). To do this, RNA prepared
from total splenocytes was analyzed by RT±PCR. As
shown in Figure 2B, comparable levels of both H-2Oa
and H-2Ob transcripts are found between CIITA (1/1)
and CIITA (2/2) mice.
IFNg-Inducible Expression of MHC Class II
Genes Is Impaired in CIITA (2/2) Mice
The expression of MHC class II genes can be induced
in macrophages upon activation with IFNg. We therefore
examined whether I-A expression is inducible in macro-
phages upon IFNg stimulation in the absence of CIITA.
Resident peritoneal macrophages were isolated from
both wild-type and CIITA (2/2) mice, treated with IFNg
for 2 days, and analyzed by flow cytometry. I-A expres-
sion was induced after wild-type macrophages were
treated with IFNg (Figure 2). In contrast, macrophages
derived from CIITA (2/2) mice did not express MHC
class II molecules upon IFNg stimulation (Figure 2). MHC
class I molecules were, however, induced normally in
CIITA (2/2) macrophages (data not shown), showing
that the IFNg signaling pathway is unaffected in these
mice.
We also tested whether cells from CIITA (2/2) mice
other than macrophages express MHC class II mole-
cules upon IFNg treatment. To do this, mice were in-
jected intravenously with IFNg for 3 consecutive daysFigure 2. Expression of MHC Class II Molecules
and the expression of MHC class II was analyzed by(A) Cell surface expression of conventional MHC class II molecules.
either flow cytometry or immunohistochemistry. InSingle-cell suspensions were prepared from spleen of wild-type
(1/1) and CIITA-deficient mice (2/2). Cells (1 3 106) were analyzed agreement with previous studies (Momburg et al.,1986a,
by two-color staining using biotinylated I-Ab (AF6-120, Pharmingen) 1986b), the constitutive expression of MHC class I mole-
followed by phycoerythrin-conjugated avidin and fluorescein iso- cules was detected in many organs tested, such as
thiocyanate (FITC)-conjugated B220 (RA3±6B2, Pharmingen) for B
spleen, thymus, liver, kidney, heart, and lung of bothcells, FITC-conjugated N418 (gift of K. Bottomly, Yale University)
CIITA (1/1) and CIITA (2/2) mice and levels were in-for dendritic cells, or FITC-conjugated MacI for macrophages (gift
creased upon IFNg injection (data not shown). Althoughof K. Bottomly, Yale University).
(B) The expression of nonconventional MHC class II molecules. Total CIITA (1/1) mice showed inducible expression of MHC
RNA was prepared from spleen and first-strand cDNA was synthe- class II in spleen, thymus, liver, and lung, MHC class II
sized using 2 mg of DNAse I-digested RNA and reverse transcriptase molecules were not detected from organs of CIITA (2/2)
(GIBCO BRL). PCR was performed as described previously (Chang
mice with the exception of thymus, which showedet al., 1994).
sparse positive staining for MHC class II (Figure 3). How-
ever, MHC class II level in the thymus of CIITA (2/2)
Previous studies showed that CIITA regulates all MHC was not inducible upon IFNg injection (data not shown).
class II genes (Steimle et al., 1993). To test whether the To characterize the nature of the cells expressing
expression of I-E is affected by CIITA deficiency, RNA MHC class II molecules in the thymus of CIITA (2/2)
from total splenocytes were analyzed. Since CIITA (2/2) mice, thymic sections were stained with various anti-
mice do not express I-E protein due to a mutation in bodies. As shown previously (Cosgrove et al., 1991;
the Ea gene (Mathis et al., 1983), we analyzed the level Grusby et al., 1991), in the control thymus MHC class
of Eb gene transcripts by RT±PCR. As shown in Figure II is confined to all cortical epithelial cells, medullary
4, Eb transcripts are barely detectable in CIITA (2/2) epithelial cells, and interdigitating cells (Figure 3A). In
splenocytes. It should be noted that the very low level contrast, MHC class II molecules in CIITA (2/2) mice
of Aa transcripts were detectable in CIITA (2/2) mice. are expressed only in subsets of stromal cells (Figure
This shows that CIITA regulates the transcription of both 3B). In these mice, cortical MHC class II expression is
MHC class II, I-A and I-E. confined to epithelial reticular cells (compare Figures
We also examined the expression of I-A on dendritic 3B and 3C), but not all epithelial cells express MHC
cells that normally express high levels of MHC class II class II molecules. Even for those cells that stained posi-
molecules on the cell surface. Dendritic cells were first tive, the staining intensity varies. Small groups of epithe-
enriched from total splenocytes and stained with the lial cells deeper in the cortex express MHC class II at
dendritic cell marker (N418) and I-A. Dendritic cells from higher levels than other MHC class II±expressing cells.
CIITA (2/2) mice did not express I-A, whereas wild-type Bright MHC class II±positive cells are found in the me-
dulla, characterized by strong cytoplasmic staining.dendritic cells expressed high levels of I-A (Figure 2A).
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Figure 3. Immunohistochemistry of Thymic Sections of CIITA (2/2) Mice
Thymic section of the wild-type (A) and CIITA (2/2) (B) mice were stained with M5/114 for MHC class II molecules. Adjacent sections of CIITA
(2/2) mice were stained with NLDC145 (C), ER-TR5 (D), a mix of three anti-macrophage monoclonal antibodies (F4/80, ER-MP3, ER-TR9) (E),
and ER-TR7 (F). C, cortex; M, medulla; ca, thymic capsule. The arrows in B±F indicate the cortico±medullary junction. The asterisk indicates
reticular-free domains.
Such cells are most probably interdigitating reticular The MHC class II molecules detected in the thymus
of CIITA (2/2) mice is bona fide I-A, not I-E, becausecells (IDCs), since this staining pattern does not corre-
spond to staining patterns observed in adjacent sec- neither thymic section of CIITA (2/2) mice stained with
an isotype-matched control antibody to I-E (a class IItions stained with antibodies to medullary epithelial cells
(Figure 3D), macrophages (Figure 3E), or fibroblasts (Fig- molecules not expressed in H-2b mice due to a mutation
in the Ea gene; Mathis et al., 1983) nor thymic sectionsure 3F). Furthermore, the cell size, together with the
bright cytoplasmic MHC class II expression is indicative of Ab (2/2) mouse stained with the same I-A antibody
showed positive staining (data not shown).of IDCs (Rouse and van Ewijk, 1979; van Ewijk et al.,
1980). The general stromal architecture of the thymus
of CIITA (2/2) mice corresponds to the thymus of con- Reduced Expression of Ii and H-2M
in CIITA (2/2) Micetrol mice except for the presence of reticular-free areas
(Figures 3B±3F, asterisks). Such areas not only occur in We and others have previously shown that expression
of CIITA in cell lines activates not only the expressionthe medulla but also are found in the cortex. The role
of such areas is, at present, uncertain. of HLA-DR but also the Ii and HLA-DM genes involved
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direct CD4 T cell development. T cells from lymph nodes
of both CIITA (1/1) and (2/2) mice were prepared and
analyzed (Figure 5A). Although CIITA (1/1) mice showed
normal representation of CD4 T cells in the periphery,
there was a drastic reduction of CD4 T cells in CIITA
(2/2) mice (Figure 5A). The remaining CD41 cells ex-
press high levels of CD44, increased levels of CD69 and
IL-2R, but lower levels of ab T cell receptor (TCR) on
the cell surface (Figure 5A). These CD4 T cells show a
similar phenotype to the CD4 T cells in the periphery of
Ab (2/2) mice (Chan et al., 1993).
T cells in the thymus were also examined in the CIITA
(2/2) mice. As expected from the peripheral T cell pro-
file, CD4 single-positive T cells are not present in CIITA
(2/2) mice (Figure 5B). There is, however, a residual
population of cells that has been described previously
to be at an intermediate stage of development, which
are CD4hiCD8int. This cell population does not show much
difference in the expression of the cell surface markers,
CD44, HSA, and IL-2R, compared with the same popula-
tion of CIITA (1/1) thymocytes.
Given that there is a massive reduction of mature
CD41 T cells in the periphery of CIITA (2/2) mice, we
have tested the T cell repertoire with a panel of Va and
Vb antibodies in CIITA (2/2) mice. There was no major
difference in the TCR usage of CD4 T cells with the
exception of Va2- and Vb14-expressing T cells that were
reduced in CIITA (2/2) as compared with CIITA (1/1)
mice (Table 1). CD8 T cells, however, do not show any
alteration of the TCR repertoire. These results are con-
sistent with data generated previously using Ab (2/2)
mice (Chan et al., 1993).
T Cell Function
Figure 4. Expression of Ii and H-2M Genes in CIITA (1/1) and (2/2) To assess whether T cells have any intrinsic defects
Mice due to CIITA deficiency, T cells were tested for their
Total RNA was prepared from spleen and first-strand cDNA was proliferation against various stimuli. First, we stimulated
synthesized using 2 mg of DNAse I-digested RNA and reverse tran- total lymph node T cells with either concanavalin A
scriptase (GIBCO BRL). PCR was performed as described (Chang
(ConA) or anti-CD3 antibody and examined them for theet al., 1994). The control lane has the same components except
expression of different activation markers. The CD44,first-strand product.
CD69, and IL-2R expression pattern of CD4 and CD8 T
cells from wild-type and CIITA (2/2) mice was indistin-
guishable (data not shown). In addition, T cells fromin antigen presentation (Chang and Flavell, 1995; Chin
et al., 1995; Kern et al., 1995). To examine whether CIITA CIITA (2/2) mice proliferated normally upon activation
with ConA or anti-CD3 antibody, suggesting that theis required for the expression of these genes in vivo,
RNA prepared from total splenocytes was analyzed by TCR-mediated response is not impaired in CIITA (2/2)
mice (Figures 6A and 6B). T cells were also tested forRT±PCR. As shown in Figure 4, the levels of Ii and H-2M
gene transcripts are substantially decreased in CIITA allogeneic responses. We first analyzed the response
of totalT cells from CIITA (2/2) mice toallogeneic stimu-(2/2) splenocytes, suggesting that CIITA is required for
the optimal expression of these genes. lator B10.BR splenocytes (class I and class II difference).
As shown in Figure 6, T cells from CIITA (2/2) mice
showed comparable proliferation to CIITA (1/1) miceLack of Positive Selection of CD4
T Cells in CIITA (2/2) Mice when B10.BR splenocytes were used as stimulators
(Figure 6C). However, T cells from CIITA (1/1) but notIt is believed that normal development of mature CD41
T cells requires MHC class II molecules to be present from CIITA (2/2) mice proliferated against splenocytes
from bm12 mice, whose MHC differs only at the MHCon thymic epithelial cells (Denning et al., 1988; Hugo et
al., 1992; Jenkinson et al., 1992; van Ewijk et al., 1994; class II locus, indicating that CD4 T cell responses were
greatly diminished, most likely owing to the reductionHollander et al., 1995). Since CIITA (2/2) mice exhibit
an unusual pattern of MHC class II expression in the of peripheral CD4 T cells (Figure 6D).
We have tested whether CD41 cells from CIITA (2/2)thymus, the profile of T cells in the periphery was exam-
ined to determine whether the residual MHC class II mice can respond to antigen stimulation. To do this,
mice were immunized with the T-dependent antigenmolecules in the CIITA (2/2) thymus were sufficient to
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Figure 5. Analysis of T Cells from CIITA-Defi-
cient Mice
Single-cell suspension was prepared from
lymph nodes (A) and thymus (B) of control
(1/1) and CIITA (2/2) mice and analyzed by
three-color flow cytometry as described in
Experimental Procedures. The leftmost pan-
els are dot-plots of cells stained for CD4
and CD8. To the right are profiles of each
staining indicated for gated CD41CD82 and
CD42CD81 populations.
keyhole limpet hemocyanin (KLH) and analyzed. T cells appropriatematuration of CD4 Tcells, such as medullary
epithelium (van Ewijk et al., 1988; Burkly et al., 1990),were purified from draining lymph nodes 9 days after
immunization and their proliferative responses against or that the functional property of these thymic epithelial
cellswould depend onappropriate MHC class II±peptideKLH were measured. As predicted from the absence of
MHC class II, T cells from CIITA (2/2) mice proliferate complexes, which may be deficient in the CIITA (2/2)
thymus even in the presence of MHC class II expression.very poorly, indicating that these mice do not respond
to KLH immunization (Figure 6E). In this case, CD4 T cells would not develop in the CIITA
(2/2) thymus, but they would mature if they are present
in an appropriate selecting environment such as theCD4 T Cells Derived from Mice Lacking CIITA
Can Develop Normally in a Wild-Type CIITA (1/1) thymus. We, therefore, tested these hypoth-
eses by performing cell transfer experiments. Day 16Thymic Environment
Despite MHC class II expression in the thymus of CIITA fetal liver cells from either CIITA (1/1) or CIITA (2/2)
embryos were isolated and transferred into irradiated(2/2) mice, CD4 T cells are not selected and matured.
There are two possible explanations for this phenotype. CIITA (1/1) or CIITA (2/2) recipients. In addition, we
used irradiated C57BL/6 Thy-1.1 mice, which differ atThe first is that CIITA may be a critical factor for control-
ling CD4 T cell development. If this were true, CD4 T the Thy-1 locus, as recipients to distinguish donor
C57BL/6 cells (Thy-1.2) from the recipient (Thy-1.1).cells would not develop without CIITA regardless of
MHC class II expression in the thymus. The other, more Cells from spleen, thymus, and lymph nodes from both
chimeric animals were analyzed 2 months after transferlikely, possibility, however, is that CIITA deficiency re-
sults in a defect in thymic epithelial cells, not in CD4 T for their T cell profiles. In chimeric mice where the recipi-
ent and the donor were CIITA (1/1), peripheral CD41cells. This could be due either to a subpopulation of
thymic epithelial cells expressing class II molecules that and CD81 T cells were reconstituted at normal levels
(Figure 7A). In contrast, the irradiated CIITA (2/2) miceis unable toprovide all thenecessary signals required for
Mice Lacking CIITA
173
Figure 6. Proliferative Response of T Cells
(A±B) Response of lymph node T cells to
ConA (A) or anti-CD3 antibodystimulation (B).
T cells (2 3 105) from CIITA (1/1) (open cir-
cles) and CIITA (2/2) (open squares) mice
were stimulated with different concentrations
of stimuli for 72 hr. Proliferative responses
were measured by [3H]thymidine incorpo-
ration.
(C±D) Allogeneic response of T cells against
B10.BR splenocytes (C) or bm12 splenocytes
(D). Lymph node cells (2 3 105) from CIITA
(1/1) (circles) and CIITA (2/2) (squares) mice
were stimulated with different numbers of al-
logeneic splenocytes (open symbols) or syn-
geneic C57BL/6 (B6) splenocytes (closed
symbols) for 72 hr.
(E) KLH recall response of T cells. Lymph
node T cells were isolated from CIITA (1/1)
(open circles) and CIITA (2/2) (open squares)
mice immunized in vivo with 50 mg of KLH
and stimulated in vitro in the presence of in-
creasing amount of KLH. For comparison, un-
immunized CIITA (1/1) (closed circles) and
CIITA (2/2) (closed squares) are shown.
reconstituted with either CIITA (1/1) or CIITA (2/2) do- Discussion
nor cells did not show significant reconstitution of CD4
T cells but did generate levels of CD8 T cells comparable CIITA is believed to be required for the constitutive and
IFNg-inducible expression of MHC class II genesto wild type (Figures 7B and 7D). CIITA (2/2) donor
cells, however, repopulated the CD4 T cell compartment (Steimle et al., 1993, 1994; Chang et al., 1994). Here, we
have shown that CIITA is a critical transactivator forin irradiated wild-type mice to a comparable level as the
reconstitution with CIITA (1/1) donor cells (Figure 7C). both constitutive and IFNg-inducible expression of MHC
class II genes in vivo. CIITA (2/2) mice, therefore, reca-We also tested whether these cells are derived from
donor cells rather than from residual cells that survived pitulate the phenotype of human BLS-2 patients who
show lack of MHC class II molecules on all antigen-in recipients after irradiation. As shown in Figures 7E
and 7F, B cells in CIITA (2/2) mice reconstituted with presenting cells and reduced number of CD4 T cells in
the periphery. It should be noted that both Aa and EbCIITA (1/1) cells or CIITA (1/1) mice reconstituted with
CIITA (2/2) cells were I-A positive and negative, respec- transcripts are eliminated in CIITA (2/2) mice, sug-
gesting that CIITA regulates both loci and possibly alltively, confirming that they are derived from donor cells.
Furthermore, C57BL/6 Thy-1.1 mice reconstituted with MHC class II genes. This is consistent with previous
studies, which show that human BLS-2 patients lackCIITA (2/2) donor cells (Thy-1.2) showed mature CD4
T cells in the periphery, the majority of which were Thy- HLA-DR, DP, and DQ transcripts and the transfection
of CIITA into cells defective in CIITA expression restores1.2 positive cells (Figures 7G and 7H). These data sug-
gest that the lack of positive selection of CD4 T cells in the expression of all these MHC class II genes (Steimle
et al., 1993). This observation is not surprising sinceCIITA (2/2) mice is not due to an intrinsic defect of CD4
T cells. The most reasonable explanation is that the MHC class II genes share common promoter elements,
in particular the X box, which has been shown to be thesubset of epithelial cells expressing MHC class II mole-
cules in the thymus of CIITA (2/2) mice is unable to most crucial element to interact with CIITA (Riley et al.,
1995; Zhou and Glimcher, 1995). However, MHC class IIsupport the maturation of CD4 T cells.
Immunity
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Table 1. TCR Variable Region Usage in Peripheral T Cells
T cells Header Va2 Va3.2 Va8 Va11 Vb2 Vb5 Vb6 Vb8.2 Vb10 Vb11 Vb14
CD4 control 12.72 0.49 2.85 4.21 6.37 3.15 8.55 17.11 4.12 5.56 10.89
13.50 0.46 2.59 8.46 4.87 5.14 8.63 22.70 4.08 3.72 9.90
CIITA 4.55 2.11 3.02 2.99 4.63 4.83 8.96 20.11 4.06 5.21 2.70
2/2 5.62 1.10 3.99 7.40 2.83 9.18 10.42 16.79 1.68 6.32 2.46
4.64 4.37 2.80 2.17 3.73 6.38 11.38 22.96 2.24 3.53 5.34
CD8 control 8.40 1.33 5.30 4.37 5.15 11.44 7.95 18.84 4.16 9.94 5.25
10.06 1.49 4.25 6.51 3.12 14.25 7.12 21.19 4.15 5.47 4.14
CIITA 7.03 2.58 4.02 1.84 5.22 10.36 7.59 16.98 5.48 5.76 2.57
2/2 8.77 1.18 4.02 4.32 4.48 17.97 8.72 15.25 3.51 3.81 3.34
6.00 2.03 3.79 1.50 3.91 15.18 8.60 15.05 3.18 5.44 3.49
Numbers represent the percent of T cells in the CD41 or CD81 population displaying a particular Va or Vb. Each value comes from triple
staining of spleen cells or lymph node cells from an individual mouse. Controls are always negative littermates.
transcription is not abolished completely in CIITA (2/2) mice respond normally to TCR-mediated stimuli. All
these data suggest that CIITA probably does not regu-mice. It is possible that MHC class II genes can be
transcribed at a very low basal level without CIITA, al- late other essential genes except for genes involved in
antigen presentation.though this level may not have physiological signifi-
cance. CIITA (2/2) and Ab (2/2) mice share many similari-
ties. Both mice show substantially reduced numbers ofIt has been reported that the regulation of nonconven-
tional MHC class II gene is different from that of conven- mature CD4 T cells in the periphery, the same pattern
of surface markers on CD4 T cells, and a similar TCRtional class II genes. The tissue distribution is limited
such that H-2O molecules are detectable in B cells and repertoire (Cosgrove et al., 1991; Grusby et al., 1991;
Chan et al., 1993). In addition, both mice show defectivethymic medullary epithelial cells (Wake and Flavell, 1985;
Karlsson et al., 1991; Karlsson and Peterson, 1992). In T cell responses to T-dependent antigens. CIITA (2/2)
mice, however, exhibit a unique phenotype. First, bothaddition, the transcription of H-2O is not inducible by
IFNg treatment, a mechanism that is believed to involve MHC class II mRNAs and, hence, cell surface I-A and
I-E molecules are absent in CIITA (2/2) mice. Thus,CIITA (Wake and Flavell, 1985; Steimle et al., 1993, 1994;
Chang et al., 1994). Our data shows that the transcription CIITA (2/2) mice carrying MHC haplotypes other than
H-2b do not express I-A as well as I-E (unpublished data).of H-2O gene does not depend on CIITA and therefore
that the mechanism of nonconventional MHC class II CIITA (2/2) mice should be, therefore, very useful to
generate mice deficient in any MHC class II haplotypetranscription is distinct from that of conventional MHC
class II genes. while retaining endogenous MHC class I gene ex-
pression.We and others have shown previously that CIITA is
required not only for the expression of HLA-DR but also Second, it is interesting that a subset of thymic epithe-
lial cells of CIITA (2/2) mice but not Ab (2/2) expressthe Ii and HLA-DM genes, which are necessary for anti-
gen presentation (Chang and Flavell, 1995; Chin et al., MHC class II even without induction by IFNg in CIITA
(2/2) mice. MHC class II is expressed in subsets of1995; Kern et al., 1995). CIITA (2/2) mice, however,
still express Ii and H-2M genes, albeit at substantially cortical epithelial cells as well as in interdigitating reticu-
lar cells in the medulla. There are two possible expla-reduced levels. This may due to subtle differences in the
organization of promoter elements among these genes. nations for this observation. First, a subset of thymic
epithelial cells might utilize different transcriptional ma-The phenotype observed, however, is consistent with
the data generated using cellsderived from BLS patients chinery for MHC class II genes. It is not yet clear what
mechanism regulates MHC class II gene transcriptionwhere there is leaky expression of HLA-DR, HLA-DM,
and Ii (Chang and Flavell, 1995). CIITA, therefore, is a in these cells but it is at least clear that MHC class II
genes can be transcribed without CIITA, possibly at acritical transactivator for the expression of MHC class
II genes but to a lesser degree for Ii and H-2M gene reduced level since MHC class II molecules are de-
tectable in the thymus of CIITA (2/2) mice. The otherexpression.
CIITA (2/2) mice are viable and B cells from CIITA possibility is that cytokine production in the thymus may
activate MHC class II transcription through a CIITA-inde-(2/2) mice do not appear to show any abnormalities
other than thedefect in the expression of MHC class II, Ii, pendent pathway. Although MHC class II molecules
were only detectable in the thymus of CIITA (2/2) miceand H-2M genes. Specifically, these B cells can mature,
proliferate normally, and up-regulate costimulatory mol- whether or not they were treated with IFNg, the most
potentknown cytokine that stimulates MHC class II geneecules upon stimulation by lipopolysaccharide or IL-4.
Our data suggests that there is an alternative way to transcription, we cannot rule out the possibility that
other cytokines can up-regulate MHC class II gene tran-up-regulate costimulatory molecules in the absence of
MHC class II, although it has shown that the up-regula- scription.
Although CIITA (2/2) mice express normal levels oftion of costimulatory molecules can be regulated by the
signaling through the MHC class II cytoplasmic domain nonconventional MHC class II mRNAs, it appears that
the MHC class II molecules detected in the thymus are(Nabavi et al., 1992). In addition, T cells of CIITA (2/2)
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Figure 7. T Cell Profiles from Chimeric Mice
after Fetal Liver Cell Transfer
Lymph node T cells were prepared and
stained with CD4 and CD8 antibodies as de-
scribed.
(A) Lymph node cells from an irradiated CIITA
(1/1) animal reconstituted with CIITA (1/1)
fetal liver cells.
(B) Lymph node cells from an irradiated CIITA
(2/2) animal reconstituted with CIITA (1/1)
fetal liver cells.
(C) Lymph node cells from an irradiated CIITA
(1/1) animal reconstituted with CIITA (2/2)
fetal liver cells.
(D) Lymph node cells from an irradiated CIITA
(2/2) animal reconstituted with CIITA (2/2)
fetal liver cells.
(E) Spleen cells from an irradiated CIITA (2/
2) animal reconstituted with CIITA (1/1) fetal
liver cells.
(F) Spleen cells from an irradiated CIITA (1/
1) animal reconstituted with CIITA (2/2) fetal
liver cells.
(G and H) Lymph node cells from an irradiated
C57BL/6 Thy1.1 animal reconstituted with CI-
ITA (2/2) fetal liver cells. We scored 25,000
events.
conventional I-A/I-E. This conclusion is drawn from the that CIITA (2/2) mice have a null mutation, which was
generated by deleting more than one exon of the CIITAfollowing observations: MHC class II molecules can be
detected in both the cortex and medulla of CIITA (2/2) gene, whereas at least some human BLS patients have
a point mutation in the splicing junction (Steimle et al.,mice, whereas H-2O expresses only in the medulla
(Karlsson et al., 1991; Karlsson and Peterson, 1992). 1993). It is possible, therefore, human BLS patient may
express mutated CIITA molecules that can function par-Furthermore, we have shown, using the same reagents,
that MHC class II molecules are not present in thymic tially. The other possibility is that the selection process
of CD4 T cells or even the requirement of CIITA for MHCsections of Ab (2/2) mice where H-2O expression is
not disturbed. It also has been suggested that the regu- class II expression in humans is different from that of
mice, although there is no direct evidence to supportlation of MHC class II expression is different in the thy-
mus because BLS patients show significant number of this notion.
Many studies demonstrate that the interaction be-CD4 T cells that appear to have a normal repertoire
(Griscelli et al., 1989; Lambert et al., 1991, 1992). None- tween thymic stromal cells and hematopoietic cells is
important for T cell development (Denning et al., 1988;theless, thymic expression of MHC class II inCIITA (2/2)
mice is not sufficient to direct positive selection of CD4 Hugo et al., 1992; Jenkinson et al., 1992; van Ewijk et
al., 1994; Hollander et al., 1995). We have shown thatT cells. This difference can be explained by the fact
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CCTGCGCTTCGACAGC-39, 59-CACCTGGCAGGTGTAAACCTC-39;the CIITA (2/2) thymus cannot select CD4 T cells even
Ii, 59-GAGGCTAGAGCCATGGATGAC-39, 59-AGATGCTTCAGATTCTwhen the T cell precursors derive from normal CIITA
CTGGG-39; Mb, 59-TGAATTTGGGGTGCTGTATCC-39, 59-TGCTGA(1/1) mice. Although it seems that T cells of CIITA (2/
ACCACGCAGGTGTAG-39; H-2Oa, 59-CCTTCTACCAATCTTACG
2) mice do not show any intrinsic defect, it is still possi- ACG-39, 59-GTGTGCCTGTGATCATGAGCAC-39; H-2Ob, 59-CTGC
ble that CIITA regulates genes other than MHC class II, AGCAGCACAACCTGCTG-39, 59-CTCCACAGATGCTTTCTGAGC-39.
Actin primers were as described (Chang et al., 1994).Ii, and H-2M genes in cell types that are essential for
CD4 T cell maturation in the thymus. We believe that
IFNg InjectionCIITA (2/2) mice can serve as an excellent model sys-
Mice 6±8 weeks of age were injected intravenously on three consec-tem to study human BLS-2 phenotype and genotype.
utive days with different doses of murine IFNg (Calbiochem, Califor-
nia), 1,000 U, 10,000 U, and 100,000 U, or with PBS as a control.
Experimental Procedures On day 4, mice were sacrificed and organs were taken out and
frozen.
Construction of Targeting Vector
Phage clones of the mouse CIITA gene were isolated from a 129/Sv Immunohistology
mouse DNA library (Stratagene, California). The probe used to Details of this method have been published before (van Ewijk et al.,
screen the library was generated from mouse B cell (A20) RNA by 1988). In brief, thymic tissue was snapfrozen in Tissue Tek and
RT±PCR using primers corresponding 2881±2092 and 3331±3352 of 6 mm frozen sections were cut on a Leitz cryostat. Sections were
human CIITA cDNA (Steimle et al., 1993). The XhoI fragment con- acetone-dipped for 5 s and stored no longer than 1 week in a dessi-
taining exons was replaced with pGK±neo cassette in the opposite cator at room temperature. Sections were incubated with mono-
transcriptional orientation. clonal antibodies in moist chambers for 30 min, followed by rinsing
of the sections in PBS supplemented with 0.01% Tween-20. Next,
Generation of Mutant Mice sections were incubated with a rabbit anti-immunoglobulin±
The linearized targeting vector was electroporated into D3 embry- horseradish peroxidase conjugate (DAKO) for 30 min. After extensive
onic stem cells and G418-resistant colonies were selected as de- rinsing, the sections were developed using di-amino-benzidene.
scribed (Elliott et al., 1994). Homologous recombinant clones were Sections were photographed with a Zeiss photomicroscope
screened first by PCR using the following primers: 59-CAGCTTGAC- equipped with Plan Apo objectives using a Schott IL4 interference
TAGGACCGGTCT-39, which is located in outside of the targeting filter. Antibodies used for immunohistology were M5/114, and Y-3JP
vector, and 59-AGTGGAGGAATGAGCTGGCCC-39 in 39 end of pGK± for MHC class II, F4/80 and MacI for macrophages, and NLDC-145
neo gene (Figure 1A). PCR conditions were 30 cycles of 1 min of for dendritic cells.
denaturation at 948C followed by 1 min of annealing at 608C and 1
min of elongation at 728C. Positive clones identified by PCR were Proliferation Assays
confirmed by Southern blot analysis after digestion with EcoRI and Lymph node T cells were isolated by depletion of B cells using goat
BamHI. These clones were expanded and injected into C57BL/6J anti-mouse immunoglobulin magnetic beads (Collaborative Re-
blastocysts. Resulting chimeric animals were backcrossed to search, Massachusetts), followed by two cycles of exposure to a
C57BL/6J mice, and germline transmission was scored by coat magnetic field. Proliferation assays were performed by plating out
color. Heterozygous mice were identified by Southern blot analysis cells in 96-well plates containing 200 ml of media. The amount of
and were intercrossed to produce homozygotes. each stimulus and the number of cells plated are indicated in the
figure legends. After 2 days, 1 mCi of [3H]thymidine was added to
Cytofluorometric Analyses each well for 12 hr and [3H]thymidine and the incorporation into DNA
The following antibodies used in experiments were purchased from was measured.
Pharmingen: AF6-120.1 for I-A; 14.4.4S for I-E; H129.1.9 for CD4;
53-6.7 for CD8; H57-597 for TCRb; M1/69 for heat-stable antigen; T-Dependent Immune Response
IM7 for CD44; H1.2F3 for CD69; 7D4 for IL-2R a chain; 1G10 for Mice 6±8 weeks of age were injected with 25 mg of KLH in complete
B7-1; GL1 for B7-2; S7 for CD43. RA3-6B2 and 53-6.7 were used Freund's adjuvant into each hind footpad and with 50 mg of KLH
for CD45RA (B220) and CD4, respectively, and they were from into the base of tail. T cells were prepared from draining lymph
GIBCO BRL. Y-3JP for I-A and MacI for macrophages were a gift nodes 9 days after immunization and cultured with KLH for 2 days.
from C. Janeway (Yale University) and K. Bottomly (Yale University), Proliferation assays were performed as described.
respectively.
Thymus, lymph nodes, and spleen cell suspensions were pre- Fetal Liver Cell Transfer
pared in Bruff's medium and the spleen erythrocytes were lysed Recipient animals were irradiated with 920 rads (1 rad 5 0.01 Gy)
by hypotonic shock. Cells were resuspended in cold phosphate- delivered by a cesium source and then rested for 1 day. Fetal liver
buffered saline (PBS) supplemented with 1% fetal bovine serum. cells from 16 days of gestation were prepared and 5 3 106 cells
Staining was performed in the same buffer. To enrich dendritic cell were injected intravenously.
population, total splenocytes were cultured for 2 hr, washed vigor-
ously to remove nonadherent cells, and incubated at 378C overnight. Acknowledgments
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